Skip to main content
Log in

Nitric oxide synthesis is increased in patients with systemic lupus erythematosus

  • ORIGINAL ARTICLE
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Nitric oxide (NO) is believed to have a role in the inflammatory process. NO production was measured in 26 patients with systemic lupus erythematosus (SLE) and 20 healthy volunteers, using spectrophotometrically determined serum nitrite and citrulline as surrogate markers. Both nitrite and citrulline levels were significantly higher in patients with SLE than in controls (P<0.001). Twelve and 10 patients, respectively, with SLE had nitrite and citrulline levels that were two standard deviations higher than the mean level of controls. These patients had a significantly higher measure of disease activity (SLE Disease Activity Index). These data show that there is increased NO production in SLE and that it may serve as a marker for disease activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 24 July 1997 / Accepted: 31 March 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wanchu, A., Khullar, M., Deodhar, S. et al. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatology International 18, 41–43 (1998). https://doi.org/10.1007/s002960050055

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002960050055

Navigation